Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kymera Therapeutics (KYMR) Total Current Liabilities (2019 - 2025)

Historic Total Current Liabilities for Kymera Therapeutics (KYMR) over the last 7 years, with Q3 2025 value amounting to $71.6 million.

  • Kymera Therapeutics' Total Current Liabilities rose 757.98% to $71.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $71.6 million, marking a year-over-year increase of 757.98%. This contributed to the annual value of $67.8 million for FY2024, which is 2091.7% down from last year.
  • Kymera Therapeutics' Total Current Liabilities amounted to $71.6 million in Q3 2025, which was up 757.98% from $87.5 million recorded in Q2 2025.
  • Over the past 5 years, Kymera Therapeutics' Total Current Liabilities peaked at $110.1 million during Q1 2021, and registered a low of $54.6 million during Q2 2023.
  • For the 5-year period, Kymera Therapeutics' Total Current Liabilities averaged around $77.9 million, with its median value being $71.6 million (2025).
  • Per our database at Business Quant, Kymera Therapeutics' Total Current Liabilities tumbled by 3759.77% in 2023 and then soared by 4086.86% in 2025.
  • Quarter analysis of 5 years shows Kymera Therapeutics' Total Current Liabilities stood at $92.5 million in 2021, then fell by 22.91% to $71.3 million in 2022, then increased by 20.11% to $85.7 million in 2023, then dropped by 20.92% to $67.8 million in 2024, then grew by 5.62% to $71.6 million in 2025.
  • Its Total Current Liabilities stands at $71.6 million for Q3 2025, versus $87.5 million for Q2 2025 and $59.0 million for Q1 2025.